Economics student and self-taught investor focused on high-growth equities and pipeline-stage pharmaceuticals. I look for businesses where the real story hasn't been priced in yet. Based in Brisbane, Australia.
No link addedEli Lilly already runs one of the fastest-growing drug businesses on earth, and its most powerful drug is not even approved yet. WHERE THE STOCK SITS TODAY The current price is around $907 (25/03/2026).Read more